β-Lactam regimens for the febrile neutropenic patient
نویسندگان
چکیده
منابع مشابه
466Skin lesions in febrile neutropenic patients
Mucahit Yemisen; Asli Vatan; Ilker Balkan; Ayse Salihoglu; Tugrul Elverdi; Emre Eskazan; Bilgul Mete; M.Cem Ar; Seniz Ongoren; Zafer Baslar; Resat Ozaras; Nese Saltoglu; Recep Ozturk; Teoman Soysal; Fehmi Tabak; Infectious Diseases, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey; Internal Medicine, Hematology Section, Istanbul University, Cerrahpasa Medical School, Istanbul, T...
متن کاملUse of β-Lactam/β-Lactamase Inhibitors for Extended-Spectrum-β-Lactamase Infections: Defining the Right Patient Population.
In a multicenter, multinational observational study that included neutropenic patients with bloodstream infections by extended-spectrum-β-lactamase-producing species, Gudiol et al. (Antimicrob. Agents Chemother. 61:e00164-17, 2017, https://doi.org/10.1128/AAC.00164-17) demonstrated that β-lactam/β-lactamase inhibitors are effective treatment options. A review of this work, however, reminds us t...
متن کاملManagement of the febrile neutropenic cancer patient: lessons from 40 years of study.
Almost forty years ago the relationship between the circulating neutrophil count and the risk of pyogenic infection was established. Since that time, through the vehicle of clinical trials, much has been learnt about the etiologies, risk factors, pathogenesis, and natural history of first and subsequent febrile neutropenic episodes. Refinements to the empirical antibacterial management has redu...
متن کاملβ-Lactam Antibiotics Renaissance.
Since the 1940s β-lactam antibiotics have been used to treat bacterial infections. However, emergence and dissemination of β-lactam resistance has reached the point where many marketed β-lactams no longer are clinically effective. The increasing prevalence of multidrug-resistant bacteria and the progressive withdrawal of pharmaceutical companies from antibiotic research have evoked a strong rea...
متن کاملGranulocyte Colony Stimulating Factor for Febrile Neutropenic Patients in Pakistan
Febrile neutropenia is a relatively frequent event in cancer patients treated with chemotherapy. In the United States, an estimated 60,000 patients a year are hospitalized for febrile neutropenia and neutropenia related infections (Cagganio et al., 2005). Our single institution data in previous two studies have shown the frequency to be ranging from 10 to 12 per month (Lal et al., 2008; Shaikh ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1990
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(19900101)65:1<9::aid-cncr2820650105>3.0.co;2-c